Newsroom
Consortium partner TI Pharma continues as Lygature
As of 1/1/2016 TI Pharma has joined forces with CTMM (Center for Translational Molecular Medicine), and continues as Lygature.
As independent intermediary for public-private cooperation, Lygature will focus on partnerships for medical innovation in the area of therapeutics as well as molecular diagnostics. For more information please visit www.lygature.org.